Clinical Trial Update: Naltrexone Implants as Relapse Prevention [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reports termination of a Phase 2/Phase 3 study evaluating Naltrexone implants for relapse prevention in opioid use disorder. The update pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Naltrexone implant (naltrexone implant)

Snippet

Sponsor: University of Oslo | Conditions: Opioid Dependency | Phase 2, Phase 3 | Status: TERMINATED